NASDAQ: CYTKCytokinetics Inc Stock Ownership
Insider buying vs selling
Have Cytokinetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sandford D. Smith | Director | 2022-01-03 | 122 | $46.00 | $5.61kBuy |
| Edward M. MD Kaye | Director | 2022-01-03 | 244 | $46.00 | $11.22kBuy |
| John T. Henderson | Director | 2022-01-03 | 244 | $46.00 | $11.22kBuy |
| Robert Califf | Director | 2022-01-03 | 122 | $46.00 | $5.61kBuy |
| Muna Bhanji | Director | 2022-01-03 | 244 | $46.00 | $11.22kBuy |
| Nancy Wysenski | Director | 2022-01-03 | 122 | $46.00 | $5.61kBuy |
| Wendall Wierenga | Director | 2022-01-03 | 122 | $46.00 | $5.61kBuy |
| Sandford D. Smith | Director | 2021-12-27 | 4,166 | $24.32 | $101.32kBuy |
| Sandford D. Smith | Director | 2021-12-27 | 4,124 | $15.43 | $63.63kBuy |
| Wendall Wierenga | Director | 2021-12-27 | 4,166 | $5.46 | $22.75kBuy |
CYTK insiders have sold more... subscribe to Premium to read more.
Ownership
CYTK Shareholders
What type of owners hold Cytokinetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 15.81% | 13,262,947 | $417.38M | Institution |
| Fmr LLC | 14.88% | 12,485,007 | $392.90M | Institution |
| Michael Schmertzler | 11.60% | 9,730,131 | $306.21M | Insider |
| Vanguard Group Inc | 6.34% | 5,314,531 | $167.25M | Institution |
| State Street Corp | 5.14% | 4,310,288 | $135.64M | Institution |
| Pfm Health Sciences LP | 3.77% | 3,159,701 | $99.44M | Institution |
| Polar Capital Holdings PLC | 3.59% | 3,014,882 | $94.88M | Institution |
| Driehaus Capital Management LLC | 3.44% | 2,889,526 | $90.93M | Institution |
| Capital Ltd Eastern | 3.44% | 2,883,845 | $90.75M | Insider |
| Farallon Capital Management LLC | 3.26% | 2,732,775 | $86.00M | Institution |
Cytokinetics Stock Ownership FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.